Introduction
============

IL-17A plays a key role in host defense against microbial infection including Gram-positive bacteria. Genetic factors contribute to the host defense. Whether genetic variation of IL-17A is associated with altered clinical outcome of severe sepsis is unknown.

Methods
=======

We tested for genetic association of IL-17A SNPs with susceptibility to infection and clinical outcome of severe sepsis using two cohorts of European ancestry (St Paul\'s Hospital (SPH) derivation cohort, *n*= 679; Vasopressin and Septic Shock Trial (VASST) validation cohort *n*= 517). The primary outcome variable was susceptibility to Gram-positive bacterial infection. The secondary outcome variable was 28-day mortality.

Results
=======

Of four tested tag SNPs (rs4711998, rs8193036, rs2275913, rs1974226) in the IL-17A gene, rs1974226 SNP was associated with altered susceptibility to Gram-positive bacterial infection in the derivation cohort (corrected *P*= 0.014). Patients who have the GG genotype of the rs1974226 SNP were more susceptible to Gram-positive bacterial infection, compared to the AG/AA genotype in the two cohorts of severe sepsis (SPH, *P*= 0.0036; VASST, *P*= 0.011) and in the subgroup having lung infection (*P*= 0.017). Furthermore, the G allele of the IL-17A rs1974226 SNP was associated with increased 28-day mortality in two cohorts (SPH, adjusted OR 1.44, 95% CI 1.04 to 2.02, *P*= 0.029; VASST, adjusted OR 1.67, 95% CI 1.17 to 2.40, *P*= 0.0052).

Conclusion
==========

IL-17A genetic variation is associated with altered susceptibility to Gram-positive infection and 28-day mortality of severe sepsis.
